Company News

Sytheon/Symbionyx Develops Psoriasis Treatment

Publishes research on isosorbide di-(methyl fumarate) as a topical treatment.

Author Image

By: TOM BRANNA

Editor

There is a new topical treatment for psoriasis, according to researchers at Sytheon/Symbionyx. The researchers published a paper, “A sensitization-free dimethyl fumarate (DMF) pro-drug, isosorbide di-(methyl fumarate) (IDMF) provides a topical treatment candidate for psoriasis,” in JID Innovations, 2021; https://doi.org/10/10106/j.xjidi.2021.100040   Dimethyl fumarate (DMF) is an effective oral treatment for psoriasis administered in Europe for nearly 60 years. Its potential, however, ha...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters